February 1, 2021
AMRI Wins 2021 CMO Leadership Awards
Recognized in All Six Performance Categories ALBANY, N.Y.–(BUSINESS WIRE)–Albany Molecular Research, Inc. (AMRI), a leading global provider of advanced contract…
Pharmaceuticals, Biotechnology and Life Sciences
Recognized in All Six Performance Categories ALBANY, N.Y.–(BUSINESS WIRE)–Albany Molecular Research, Inc. (AMRI), a leading global provider of advanced contract…
TB Alliance to leverage ZebiAI’s platform to discover novel probe compounds for important tuberculosis targets, with options for drug discovery…
– Maralixibat U.S. launch expected in second half of 2021, if approved FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM)…
– Maralixibat U.S. launch expected in second half of 2021, if approved FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM)…
Three companies founded or co-founded by Truffle represent 30% of the total valuation of the highest BioMedTech market caps of…
Three companies founded or co-founded by Truffle represent 30% of the total valuation of the highest BioMedTech market caps of…
Three companies founded or co-founded by Truffle represent 30% of the total valuation of the highest BioMedTech market caps of…
Three companies founded or co-founded by Truffle represent 30% of the total valuation of the highest BioMedTech market caps of…
– Adamas grants Zydus license for generic version of GOCOVRI® as of March 4, 2030 – EMERYVILLE, Calif.–(BUSINESS WIRE)–Adamas Pharmaceuticals,…
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) has been named to FORTUNE magazine’s “World’s…